Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03478800 · ClinicalTrials.gov registry record · NA

Acupuncture in Adolescent Football Players

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT03478800: Completed NA study, sponsored by Mayo Clinic.

NCT03478800 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03478800, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

Is it feasible to perform acupuncture in the training field after sport performance in adolescent football players? Does acupuncture provide a decrease in muscle soreness and improvement in overall sense of well-being in the adolescent football population?

Primary Outcome

Musculoskeletal pain or soreness will be measured by a Football Acupuncture Survey designed by the investigators. Participants will first be asked if they had muscle soreness or pain in the last 24-48 hours and if so, if they used any modalities to alleviate it (ice, heat, massage etc) or medications (and if so, which ones). Participants will then be asked about the presence and location of current muscle soreness and to rate the soreness on a 10 point scale with 0 being 'no muscle soreness' and

Interventions

  • PROCEDURE Acupuncture

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-08-13
Est. Completion 2018-08-29
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03478800 record still lists

NCT03478800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.

NCT03478800 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03478800 about?

NCT03478800 is a clinical study titled "Acupuncture in Adolescent Football Players". Is it feasible to perform acupuncture in the training field after sport performance in adolescent football players? Does acupuncture provide a decrease in muscle soreness and improvement in overall sense of well-being in the adolescent football population?

What is the current status of trial NCT03478800?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-08-13. Estimated completion is 2018-08-29.

What interventions are being tested in trial NCT03478800?

The interventions under investigation include: Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT03478800?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03478800's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03478800, the US trial registry maintained by the National Library of Medicine. NCT03478800 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.